SAGA Diagnostics is a personalized cancer genomics and disease monitoring company that offers molecular genetic testing of tissue biopsies and non-invasive “liquid biopsies” such as blood samples. SAGA helps pharmaceutical companies, scientists, and biomedical laboratory providers to detect actionable mutations, stratify patient groups, and monitor treatment response more accurately and to an industry-leading lower limit of detection of 0.001%.  Analysis of circulating tumor DNA using these proprietary technologies gives SAGA unique ultrasensitivity, ultimately giving patients peace of mind.
Follow SAGA on Twitter @SAGAdiagnostics and on LinkedIn.